CA1256430A - Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same - Google Patents
Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the sameInfo
- Publication number
- CA1256430A CA1256430A CA000500970A CA500970A CA1256430A CA 1256430 A CA1256430 A CA 1256430A CA 000500970 A CA000500970 A CA 000500970A CA 500970 A CA500970 A CA 500970A CA 1256430 A CA1256430 A CA 1256430A
- Authority
- CA
- Canada
- Prior art keywords
- group
- formula
- carbon atoms
- hydrogen atom
- group represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2038485 | 1985-02-05 | ||
| JP20384/1985 | 1985-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1256430A true CA1256430A (en) | 1989-06-27 |
Family
ID=12025537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000500970A Expired CA1256430A (en) | 1985-02-05 | 1986-02-03 | Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0190709B1 (https=) |
| JP (1) | JPS63183587A (https=) |
| CA (1) | CA1256430A (https=) |
| DE (1) | DE3667286D1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2544375B2 (ja) * | 1986-07-14 | 1996-10-16 | 鐘淵化学工業株式会社 | アルキル置換ベンゾキサジノリフアマイシン誘導体 |
| DE68924722T2 (de) * | 1988-03-18 | 1996-04-18 | Kanegafuchi Chemical Ind | Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel. |
| CA1304363C (en) * | 1988-11-01 | 1992-06-30 | Takehiko Yamane | 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
| JP2620399B2 (ja) * | 1990-08-20 | 1997-06-11 | 鐘淵化学工業株式会社 | 3′―アルキルまたはアリールシリルオキシベンゾキサジノリファマイシン誘導体 |
| US5981522A (en) * | 1995-09-01 | 1999-11-09 | Kaneka Corporation | Treatment of disease caused by infection of Helicobacter |
| KR100407849B1 (ko) * | 1995-09-01 | 2004-05-07 | 가네가후치 가가쿠고교 가부시키가이샤 | 헬리코박터의감염에기인하는질환의치료제 |
| JP3963976B2 (ja) | 1995-12-08 | 2007-08-22 | 株式会社カネカ | クラミジア感染症治療剤 |
| EP0861660B9 (en) * | 1997-02-28 | 2006-06-28 | Kaneka Corporation | Curative medicine for disease caused by infection of Helicobacter |
| WO1999006047A1 (en) * | 1997-07-29 | 1999-02-11 | Kaneka Corporation | Use of rifamycin derivative for treating mastitis in a domestic animal |
| US6486161B1 (en) | 1998-07-29 | 2002-11-26 | Kaneka Corporation | Use of rifamycin derivative for treating mastitis in a domestic animal |
| CA2536378A1 (en) * | 2003-08-22 | 2005-03-10 | Activbiotics, Inc. | Rifamycin analogs and uses thereof |
| US7256187B2 (en) | 2004-03-10 | 2007-08-14 | Cumbre Pharmaceuticals Inc. | Rifamycin C-11 oxime derivatives effective against drug-resistant microbes |
| US7265107B2 (en) | 2004-03-10 | 2007-09-04 | Cumbre Pharmaceuticals Inc. | Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes |
| BR112018014355A2 (pt) | 2016-03-04 | 2018-12-18 | Genentech, Inc. | processos para a preparação de f-benzoxazinorifamicina i e para a preparação de 2-amino-5-fluorobenzeno-1,3-diol iii |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL130099C (https=) * | 1963-10-11 |
-
1986
- 1986-01-20 JP JP61009432A patent/JPS63183587A/ja active Granted
- 1986-02-03 CA CA000500970A patent/CA1256430A/en not_active Expired
- 1986-02-04 DE DE8686101392T patent/DE3667286D1/de not_active Expired - Lifetime
- 1986-02-04 EP EP86101392A patent/EP0190709B1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0190709A1 (en) | 1986-08-13 |
| DE3667286D1 (de) | 1990-01-11 |
| EP0190709B1 (en) | 1989-12-06 |
| JPH0557275B2 (https=) | 1993-08-23 |
| JPS63183587A (ja) | 1988-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1256430A (en) | Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same | |
| CA1304363C (en) | 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same | |
| EP0253340B1 (en) | Alkyl-substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same | |
| US4248870A (en) | Maytansinoids and use | |
| Hochstein et al. | Magnamycin B, a second antibiotic from Streptomyces halstedii | |
| IE46883B1 (en) | Cyclosporin derivatives | |
| US4690919A (en) | Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same | |
| IL99889A0 (en) | Azasteroid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| US3514452A (en) | Novel derivatives of mitomycin a,mitomycin b,and mitomycin c | |
| CA1293503C (en) | Substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same | |
| Braish et al. | Synthesis of (S, S)-and (R, R)-2-alkyl-2, 5-diazabicyclo [2.2. 1] heptanes | |
| NO158743B (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive mitosanforbindelser. | |
| CA1212670A (en) | Water-soluble rifampicin derivatives | |
| US4562203A (en) | Rifamycins derivatives and preparation and pharmaceutical compositions thereof | |
| Cahill et al. | Proton magnetic resonance studies of compounds with bridgehead nitrogen atoms—XIX Configurational and conformational studies with derivatives of hexahydropyrido [2, 1‐c][1, 4] oxazin‐4 (3H)‐ones | |
| US3576004A (en) | Novel ring-e substituted 4-cyano-3-secoyohimbanes | |
| EP0049683A2 (de) | Imidazo-Rifamycine, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate sowie ihre Verwendung | |
| GB1603127A (en) | Rifamycin compounds | |
| WO1996035431A1 (en) | Derivatives of 2,3:4,6-di-o-isopropylidene-alpha-l-xylo-2-hexulofluranosonic acid | |
| Portoghese et al. | Stereochemical studies on medicinal agents. VIII. Absolute stereochemistries of isomethadol isomers | |
| Mosti et al. | Reaction of dichloroketene and sulfene with N, N‐disubstituted α‐aminomethyleneketones. Synthesis of pyrano [2, 3‐e] indazole and 1, 2‐oxathiino [6, 5‐e] indazole derivatives | |
| Brown et al. | Condoxine: A novel oxindole system from secologanin aglycone. | |
| US3853917A (en) | Process for the preparation of d-glucarolactone derivatives | |
| JPH03101681A (ja) | 5’―(4―プロピルまたは4―イソプロピルピペラジニル)ベンゾキサジノリファマイシン誘導体 | |
| HU190969B (en) | Process for preparing aminoalkyl-imidazo-thidaiazolyl-alkane-carboxylic acid amides and pharmaceutical compositions thereof as active substances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry | ||
| MKEX | Expiry |
Effective date: 20060627 |